Oncology Ventures is a venture capital firm founded by Ben Freeberg that invests in healthcare data and AI startups enhancing cancer care and research. The firm focuses on data-driven technologies across early detection, precision diagnostics, care navigation, and non-drug infrastructure.
43% of their portfolio is in Healthcare. Deal activity increased 250% year-over-year (7 deals in the last 12 months). Their most common stage is series-a (43% of deals). Average disclosed round size is $9.5M (across 9 rounds with reported amounts).
Portfolio
11
Fund Size
$62M
Top Stage
Series A
Last 12 Mo
7
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
14 investments
| Company | Round | Amount | Date |
|---|---|---|---|
 Lumonus | Series B | — | Mar 2026 |
 Risa | Series A | — | Jan 2026 |
| RRisa Labs | Series A | $11.1M | Jan 2026 |
 Wellbeam | Series A | $10M | Nov 2025 |
| Lumonus | Series B | — | Nov 2025 |
 Daymark Health | Series A | $20M | Sep 2025 |
| DDaymark | Series A | $20M | Sep 2025 |
 IgniteData | Series A | — | Aug 2025 |
| Risa | Seed | $3.5M | Apr 2025 |
| DDaymark | Seed | $11.5M | Apr 2025 |
| MmPATH | Growth | $1M | Jan 2024 |
 Health Universe | Pre-Seed | — | Jan 2023 |
 Oncoverycare | Seed | $4.5M | — |
 Risa | Seed | $3.5M | — |
Top Co-Investors
z21 Ventures4 shared
Maverick Ventures3 shared
Yosemite3 shared
General Catalyst2 shared
Cencora Ventures2 shared
Optum Ventures2 shared
The Blue Venture Fund2 shared
Healthier Capital2 shared
Investible2 shared
SpringTide1 shared
FCA Venture Partners1 shared
F-Prime Capital1 shared
Wittington Ventures1 shared
Techstars1 shared
Fidelity Investments1 shared
.406 Ventures1 shared
University of Chicago1 shared
Brandon Capital1 shared
Twelve Below1 shared
Susa Ventures1 shared
Last updated: 9 September 2026